Diffuse Alveolar Hemorrhage after Adalimumab Treatment of Rheumatoid Arthritis / 대한내과학회지
Korean Journal of Medicine
;
: 439-444, 2013.
Article
in Korean
| WPRIM
| ID: wpr-169739
ABSTRACT
Diffuse alveolar hemorrhage (DAH) is a life-threatening condition involving hemorrhage originating in the pulmonary microvasculature. The clinical syndrome is characterized by hemoptysis, hypoxemic respiratory failure, low-grade fever, and diffuse pulmonary infiltrates. The majority of cases of DAH are caused by pulmonary renal syndromes, connective tissue disorders, and drugs. Here, we present a case of DAH associated with adalimumab treatment in a patient with rheumatoid arthritis.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Arthritis, Rheumatoid
/
Respiratory Insufficiency
/
Connective Tissue
/
Microvessels
/
Fever
/
Antibodies, Monoclonal, Humanized
/
Adalimumab
/
Hemoptysis
/
Hemorrhage
Limits:
Humans
Language:
Korean
Journal:
Korean Journal of Medicine
Year:
2013
Type:
Article
Similar
MEDLINE
...
LILACS
LIS